E
Sell
10/31/2024Downgrade
Acelyrin, Inc. (SLRN) was downgraded to E+ from D- on 10/31/2024 due to a decline in the volatility index and total return index.
D
Sell
10/16/2024Upgraded
Acelyrin, Inc. (SLRN) was upgraded to D- from E+ on 10/16/2024 due to an increase in the volatility index and total return index.
E
Sell
3/28/2024Downgrade
Acelyrin, Inc. (SLRN) was downgraded to E+ from D- on 3/28/2024 due to a noticeable decline in the efficiency index, volatility index and total return index. Net income declined 13.43% from -$83.94M to -$95.21M, and total capital declined 10.36% from $733.81M to $657.75M.
D
Sell
11/13/2023Downgrade
Acelyrin, Inc. (SLRN) was downgraded to D- from D on 11/13/2023 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 121.15% from -$42.7M to -$94.42M, earnings per share declined from -$0.3993 to -$0.8665, and operating cash flow declined 23.73% from -$31.62M to -$39.13M.
D
Sell
8/17/2023None
Acelyrin, Inc. (SLRN) was downgraded to D from U on 08/17/2023.
